Critical endpoint and analytical phase diagram of attractive hard-core Yukawa spheres.

J Phys Chem B

Forschungszentrum Jülich, Institut für Festkörperforschung, 52425 Jülich,

Published: October 2006

We analytically calculate the gas-liquid critical endpoint (cep) for hard spheres with a Yukawa attraction. This cep is a boundary condition for the existence of a liquid. We use an analytical Helmholtz energy expression for the attractive Yukawa (hard) spheres based on the first-order mean spherical approximation to the attractive Yukawa potential by Tang and Lu (J. Chem. Phys. 1993, 99, 9828). This theory and our analytical simplification of it predict the gas-liquid and fluid-solid phase behavior, as found from computer simulations, very accurately as long as the range 1/kappa of attraction is not too short. We find that the cep is situated at kappasigma approximately 6 and at a contact potential around 2 kT. It follows that a liquid state is only possible when the attraction range is longer than (1/6) of the particle diameter sigma, and the attraction strength is smaller than 2 kT. The liquid region does not span more than 0.6 kT in strength, and there is also a relatively narrow window for the attraction range.

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp063650jDOI Listing

Publication Analysis

Top Keywords

critical endpoint
8
hard spheres
8
attractive yukawa
8
attraction range
8
attraction
5
endpoint analytical
4
analytical phase
4
phase diagram
4
diagram attractive
4
attractive hard-core
4

Similar Publications

Background: Despite the availability of several biologics for ulcerative colitis (UC), there remains a critical need to identify first-line treatment biologics. The superiority of infliximab (IFX) over vedolizumab (VED) and ustekinumab (UST) was evaluated as initial UC treatments in patients with biologic-naïve UC.

Methods: This multicenter, randomized control trial was conducted across 20 Japanese medical institutions.

View Article and Find Full Text PDF

Objectives: Acute type A aortic dissection is a life-threatening cardiovascular disease commonly seen in emergency department, resulting in substantial mortality and morbidity. We aimed to investigate the prognostic value of N-terminal pro-B type natriuretic peptide (NT-proBNP) among this critically ill population.

Design: The design of this study was a retrospective cohort study.

View Article and Find Full Text PDF

Background: There are little available data about the impact of geriatric nutritional risk index (GNRI) on clinical outcomes following endovascular therapy (EVT) in chronic limb-threatening ischemia (CLTI) regarding the severities of renal dysfunction (RD).

Aims: The aim of this study is to evaluate the impact of GNRI on clinical outcomes following EVT in CLTI regarding the severities of RD.

Methods: We enrolled 705 consecutive CLTI cases treated with EVT between January 2010 and December 2019 at our hospital.

View Article and Find Full Text PDF

Background: Dexrazoxane has been studied for its ability to prevent anthracycline-induced cardiac dysfunction (AICD) in several trials but its use in clinical practice remains limited. This is related to the low to moderate quality of the generated evidence, safety concerns and restricted prescribing indications. Additional randomized trials are needed before this drug can be routinely integrated into cardio-oncology clinical practice.

View Article and Find Full Text PDF

Oxidative balance score (OBS) is a composite measures that assess the balance between pro-oxidant and antioxidant factors in an individual's diet and lifestyle, with higher scores indicating greater antioxidant exposure. Despite its potential significance, there is a limited body of research exploring the relationship between OBS and all-cause and cardiovascular disease (CVD) mortality specifically in younger patients with diabetes. We aimed to investigate the possible relationship between OBS and all-cause and CVD mortality in younger patients with diabetes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!